Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
2.
Clin Infect Dis ; 29(3): 561-7, 1999 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-10530448

RESUMO

Chagas' disease was present in 17.22% of persons undergoing kidney transplantation in an Argentine Hospital. The criterion for attributing reactivation of chronic Chagas' disease and transmission of Trypanosoma cruzi to grafts was detection of parasites in blood (patent parasitemia) or tissues. Reactivation was diagnosed in 5 (21.7%) of 23 recipients. Ten (43.4%) of 23 chagasic recipients without reactivation of chronic Chagas' disease had abrogation of serological reactivity. T. cruzi infection was transmitted to 3 (18.7%) of 16 non-chagasic recipients. Reactivation and infection were diagnosed by patent parasitemia or cutaneous panniculitis. For diagnosis, detection of parasites in blood and tissues had more relevance than serology. Sequential monitoring detected early reactivation and infection, permitting application of preemptive or therapeutic therapy with benznidazole, thus inhibiting, in all patients, severe clinical disease produced by a progressive and systemic replication of the parasite.


Assuntos
Doença de Chagas/diagnóstico , Doença de Chagas/epidemiologia , Transplante de Rim/efeitos adversos , Adolescente , Adulto , Argentina/epidemiologia , Doença de Chagas/tratamento farmacológico , Doença de Chagas/etiologia , Estudos de Avaliação como Assunto , Feminino , Seguimentos , Rejeição de Enxerto , Sobrevivência de Enxerto , Humanos , Hospedeiro Imunocomprometido , Incidência , Transplante de Rim/imunologia , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Taxa de Sobrevida
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA